XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.3
Significant Agreements and Contracts (Tables)
9 Months Ended
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Contract Liability Activity
The following table presents a summary of the activity in the Company's contract liabilities related to the Chiesi Collaboration Agreement (recorded as contract liabilities on the balance sheet) during the nine months ended September 30, 2024 (in thousands):
Balance, December 31, 2023$— 
Payments received in advance160,000 
Revenue from sale of US license(76,686)
Revenue from sale of ROW license(12,050)
Revenue from PAH research and development service performance obligations satisfied during reporting period(8,132)
Revenue from PH-ILD research and development service performance obligations satisfied during reporting period(217)
     Equity Option granted to Chiesi(464)
     Effect of exchange rate changes on contract liabilities1,656 
Balance, September 30, 2024$64,107 
Schedule of Contract Revenues Disaggregated by Timing of Revenue Recognition and Excludes Royalty Revenue
The following table presents our contract revenues from Chiesi Collaboration Agreement disaggregated by timing of revenue recognition and excluding royalty revenue (in thousands):
Three Months Ended September 30, 2024
Nine Months ended September 30, 2024
Revenue from Chiesi Collaboration Agreement:
Point in Time:
US License$— $76,686 
ROW License— 12,050 
Over Time:
Revenue from PAH research and development service performance obligation satisfied during reporting period4,735 8,133 
Revenue from PH-ILD research and development service performance obligation satisfied during reporting period157 217 
Revenue from PAH research and development costs subject to reimbursement3,516 6,812 
Revenue from PH-ILD research and development costs subject to reimbursement1,086 1,419 
Effect of exchange rate changes on revenue(14)
Total revenue from Chiesi Collaboration Agreement$9,480 $105,322